Metropolitan Life Insurance CO Molecular Templates, Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $15 - $24	-2 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$9.33 - $14.05 $14,685 - $22,114	1,574 New	1,574 $19.9 Million
Q1 2021 Mar 30, 2023	SELL	$9.33 - $14.05 $61,391 - $92,449	-6,580 Reduced 80.7%	1,574 $19,000
Q1 2021 May 14, 2021	BUY	$9.33 - $14.05 $18 - $28	2 New	2 $20,000
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $69,145 - $99,723	-8,154 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$9.99 - $14.41 $81,458 - $117,499	8,154 New	8,154 $89,000
Q2 2020 Jun 26, 2023	BUY	$12.28 - $17.63 $100,131 - $143,755	8,154 New	8,154 $112,000
Q2 2020 Mar 30, 2023	BUY	$12.28 - $17.63 $26,868 - $38,574	2,188 Added 36.67%	8,154 $112,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $26,868 - $38,574	2,188 Added 36.67%	8,154 $112,000
Q1 2020 Jul 12, 2023	BUY	$11.31 - $18.26 $67,475 - $108,939	5,966 New	5,966 $79,000
Q1 2020 Mar 30, 2023	BUY	$11.31 - $18.26 $67,475 - $108,939	5,966 New	5,966 $79,000
Q1 2020 May 15, 2020	BUY	$11.31 - $18.26 $67,475 - $108,939	5,966 New	5,966 $79,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.